ATOMICC/ GEICO 78-C
Trial Description:
A randomize double-blinded, Placebo controlled, Phase II Trial of ANTI-PD1, TSR-042, as maintenance Therapy for patients with high-risk locallly advanced cervical cancer after chemo radiaton
Lead Cooperative Group:
Trial Number:
Disease Site:
Cervical
Trial Status:
Recruiting
Contact person:
aoaknin